Approaches for corneal endothelium regenerative medicine

Pere Català, Gilles Thuret, Heli Skottman, Jodhbir S. Mehta, Mohit Parekh, Sorcha Ní Dhubhghaill, Rob W.J. Collin, Rudy M.M.A. Nuijts, Stefano Ferrari, Vanessa L.S. LaPointe, Mor M. Dickman

    Research output: Contribution to journalReview Articlepeer-review

    13 Downloads (Pure)


    The state of the art therapy for treating corneal endothelial disease is transplantation. Advances in the reproducibility and accessibility of surgical techniques are increasing the number of corneal transplants, thereby causing a global deficit of donor corneas and leaving 12.7 million patients with addressable visual impairment. Approaches to regenerate the corneal endothelium offer a solution to the current tissue scarcity and a treatment to those in need. Methods for generating corneal endothelial cells into numbers that could address the current tissue shortage and the possible strategies used to deliver them have now become a therapeutic reality with clinical trials taking place in Japan, Singapore and Mexico. Nevertheless, there is still a long way before such therapies are approved by regulatory bodies and become clinical practice. Moreover, acellular corneal endothelial graft equivalents and certain drugs could provide a treatment option for specific disease conditions without the need of donor tissue or cells. Finally, with the emergence of gene modulation therapies to treat corneal endothelial disease, it would be possible to treat presymptomatic patients or those presenting early symptoms, drastically reducing the need for donor tissue. It is necessary to understand the most recent developments in this rapidly evolving field to know which conditions could be treated with which approach. This article provides an overview of the current and developing regenerative medicine therapies to treat corneal endothelial disease and provides the necessary guidance and understanding towards the treatment of corneal endothelial disease.

    Original languageEnglish
    Article number100987
    JournalProgress in Retinal and Eye Research
    Early online date2021
    Publication statusPublished - 2022
    Publication typeA2 Review article in a scientific journal


    • Cell therapy
    • Corneal endothelial disease
    • Gene therapy
    • Pharmacological modulation
    • Regenerative medicine
    • Tissue engineering

    Publication forum classification

    • Publication forum level 2

    ASJC Scopus subject areas

    • Ophthalmology
    • Sensory Systems


    Dive into the research topics of 'Approaches for corneal endothelium regenerative medicine'. Together they form a unique fingerprint.

    Cite this